InvestSMART

Noxopharm Limited (ASX: NOX) - Announcements

Current share price for NOX : $0.060 0.003 (4.76%)+

ASX company news and announcements for Noxopharm Limited (NOX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Noxopharm Limited (NOX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Noxopharm Limited (NOX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Noxopharm Limited (NOX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$18 Appendix 3B 25 Jan 2018 11:13AM $1.135 $0.060 fallen by 94.71%
$18 KZA: Receipt of securities in Noxopharm Limited (NOX) 22 Jan 2018 10:04AM $0.980 $0.060 fallen by 93.88%
$18 Section 708 Certificate 18 Jan 2018 3:46PM $1.080 $0.060 fallen by 94.44%
$18 Appendix 3B 18 Jan 2018 3:44PM $1.080 $0.060 fallen by 94.44%
$18 NOX receives FY17 R&D Tax Rebate 17 Jan 2018 11:15AM $1.080 $0.060 fallen by 94.44%
$18 Kazia Therapeutics Ltd and Noxopharm Ltd 27 Dec 2017 8:24AM $1.115 $0.060 fallen by 94.62%
$18 KZA: Kazia Therapeutics and Noxopharm 27 Dec 2017 8:24AM $1.115 $0.060 fallen by 94.62%
$18 EOY Guidance on 2018 NOX66 Clinical Development Strategy 21 Dec 2017 1:16PM $1.205 $0.060 fallen by 95.02%
$18 Section 708 Certificate 19 Dec 2017 8:24AM $1.380 $0.060 fallen by 95.65%
$18 Appendix 3B 19 Dec 2017 8:24AM $1.380 $0.060 fallen by 95.65%
$18 Response to ASX Price Query 14 Dec 2017 12:02PM $1.240 $0.060 fallen by 95.16%
$18 Appendix 3B 12 Dec 2017 6:02PM $1.215 $0.060 fallen by 95.06%
$18 Change of Registered Office 11 Dec 2017 12:50PM $1.035 $0.060 fallen by 94.20%
$18 Section 708 Certificate 7 Dec 2017 8:33AM $0.980 $0.060 fallen by 93.88%
$18 Appendix 3B 7 Dec 2017 8:32AM $0.980 $0.060 fallen by 93.88%
$18 NOX Open Briefing Corporate Presentation 6 Dec 2017 8:54AM $0.970 $0.060 fallen by 93.81%
$18 Compassionate use of NOX66 in Patients 4 Dec 2017 12:22PM $0.945 $0.060 fallen by 93.65%
$18 Nyrada Inc Opens Capital Raise - Memorandum Released 1 Dec 2017 8:31AM $0.930 $0.060 fallen by 93.55%
$18 Change of Director's Interest Notice - PM 29 Nov 2017 3:17PM $0.900 $0.060 fallen by 93.33%
$18 Change of Director's Interest Notice - ID 29 Nov 2017 3:17PM $0.900 $0.060 fallen by 93.33%
$18 Appendix 3B 29 Nov 2017 3:17PM $0.900 $0.060 fallen by 93.33%
$18 Webcast of NOX 2017 AGM 29 Nov 2017 9:49AM $0.840 $0.060 fallen by 92.86%
$18 NYX-104 delivers Key Proof-of-Concept in Stroke Animal Model 29 Nov 2017 8:45AM $0.840 $0.060 fallen by 92.86%
$18 Invitation to Open Briefing 28 Nov 2017 8:26AM $0.900 $0.060 fallen by 93.33%
$18 Results of Meeting 27 Nov 2017 2:57PM $0.850 $0.060 fallen by 92.94%

651 - 675 of 799 results

Page 27 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.